Which of the following is NOT a clinical feature of gangrene?
Alkaline phosphatase is a tumor marker of which tumor?
Which of the following parasitic infections predisposes to malignancies?
All of the following are true regarding deep partial thickness burns except?
Which of the following is NOT true of dystrophic calcification?
Dermatomyositis associated with Anti-Mi2 antibodies shows strong association with which of the following clinical features?
Apoptosis means:
CD34 is a tumor marker used for which of the following conditions?
CD-99 is a marker for which of the following tumors?
Hydropic swelling of the cell is characterized by all the following EXCEPT?
Explanation: **Explanation:** The correct answer is **D**. This question tests the distinction between **Gangrene** (a clinical condition affecting tissues, usually limbs or bowel) and **Gas Gangrene** (a specific infection) versus post-mortem changes. 1. **Why Option D is the correct answer:** "Foaming kidney" (or *organs de la mousse*) is a **post-mortem change**, not a clinical feature of gangrene in a living patient. It occurs when gas-forming organisms like *Clostridium welchii* enter the bloodstream after death and produce gas bubbles in solid organs (liver, kidney, brain). Since gangrene is a clinical diagnosis made in living tissue, post-mortem findings are excluded. 2. **Why other options are incorrect:** * **Option A & B:** These are classic signs of **Wet Gangrene**. When muscle tissue undergoes necrosis due to ischemia and subsequent bacterial putrefaction, it loses its structural integrity (loss of contractility) and emits a putrid odor due to the breakdown of proteins by anaerobic bacteria. [1] * **Option C:** The color change is a hallmark of gangrene. Hemoglobin from lysed red blood cells reacts with hydrogen sulfide ($H_2S$) produced by bacteria to form **iron sulfide**, which tints the skin dull red, green, or black. **High-Yield Clinical Pearls for NEET-PG:** * **Dry Gangrene:** Primarily due to arterial occlusion (e.g., Buerger’s disease [2]). Features a clear **line of demarcation** [1]. * **Wet Gangrene:** Occurs in moist tissues (bowel, mouth, diabetic foot). No clear line of demarcation; high risk of septicemia [1]. * **Gas Gangrene:** A specific type of wet gangrene caused by *Clostridium perfringens*, characterized by **crepitus** (gas bubbles under the skin) [1]. * **Fournier’s Gangrene:** A necrotizing fasciitis of the perineum/scrotum (surgical emergency). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 103-104. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Cardiovascular Disease, pp. 280-281.
Explanation: **Explanation:** **Alkaline Phosphatase (specifically the Placental-like isoform, PLAP)** is a highly characteristic serum and immunohistochemical marker for **Seminoma**. In the context of germ cell tumors (GCTs), PLAP is elevated in approximately 50-95% of patients with seminoma [1]. While it is not entirely specific (as it can be elevated in smokers), it remains the classic diagnostic marker for this tumor type in medical examinations. **Analysis of Incorrect Options:** * **Embryonal Carcinoma:** This tumor typically shows elevation of **hCG** and occasionally **AFP** (if mixed components are present). Its characteristic IHC marker is **CD30**. * **Yolk Sac Tumor:** The hallmark marker is **Alpha-Fetoprotein (AFP)**. It is the most common testicular tumor in infants and children and is histologically characterized by Schiller-Duval bodies. * **Endodermal Sinus Tumor:** This is simply another name for **Yolk Sac Tumor**; therefore, the primary marker remains **AFP**. **High-Yield Clinical Pearls for NEET-PG:** * **Seminoma:** Most common GCT; highly radiosensitive; markers include **PLAP**, **hCG** (in 10-15% of cases due to syncytiotrophoblasts), and **LDH** (used to monitor tumor burden) [1]. * **AFP Rule:** AFP is **never** elevated in a pure seminoma. If AFP is high, it indicates a non-seminomatous component (usually Yolk Sac). * **LDH:** A non-specific marker for all GCTs, used primarily for prognostic staging and monitoring treatment response. * **Choriocarcinoma:** Characterized by very high levels of **hCG**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 980-982.
Explanation: ### Explanation **Correct Answer: D. Schistosomiasis** **Reasoning:** Certain parasitic infections are well-recognized biological carcinogens. **Schistosomiasis** (specifically *Schistosoma haematobium*) is strongly associated with **Squamous Cell Carcinoma (SCC) of the urinary bladder** [1], [3]. The mechanism involves chronic inflammation caused by the deposition of eggs in the bladder wall, leading to squamous metaplasia, which eventually progresses to neoplasia [2], [4]. Note that while transitional cell carcinoma is the most common bladder cancer globally, in endemic areas for Schistosomiasis (like the Nile Valley), SCC is more prevalent [3]. **Analysis of Incorrect Options:** * **A. Pargibunuasus:** This appears to be a distractor or a misspelling of *Paragonimus* (Lung fluke). While *Paragonimus westermani* causes chronic lung lesions that can mimic tuberculosis or tumors on imaging, it is not a primary established risk factor for malignancy. * **B. Guinea worm (Dracunculus medinensis):** This infection involves the subcutaneous tissues. While it causes painful ulcers and secondary bacterial infections, it has no documented association with oncogenesis. * **C. Clonorchiasis:** While *Clonorchis sinensis* (Chinese liver fluke) **does** predispose to malignancy (**Cholangiocarcinoma**), the question asks which of the following predisposes to malignancies. In the context of standard medical examinations, *Schistosoma* is often the "most" classic or primary answer provided. However, if this were a multiple-select question, Clonorchiasis would also be correct. In a single-choice format, Schistosomiasis is the most frequently tested prototype. **NEET-PG High-Yield Pearls:** 1. **Schistosoma haematobium:** Bladder Cancer (Squamous Cell Carcinoma) [1]. 2. **Clonorchis sinensis & Opisthorchis viverrini:** Cholangiocarcinoma (Bile duct cancer). 3. **IARC Classification:** Both *S. haematobium* and *C. sinensis* are classified as Group 1 Carcinogens. 4. **Mechanism:** Chronic irritation $\rightarrow$ Metaplasia $\rightarrow$ Dysplasia $\rightarrow$ Neoplasia [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 406-408. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 967-968. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 968-970. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 221-222.
Explanation: Deep partial-thickness burns (Second-degree deep) involve the epidermis and the deeper layers of the dermis (reticular dermis), sparing only the deep epidermal appendages. [1] **Explanation of the Correct Answer (B):** Capillary staining (or capillary refill) is a clinical test for tissue perfusion. In deep partial-thickness burns, the subpapillary vascular plexus is significantly damaged. Consequently, **capillary refill is typically absent or sluggish** immediately. The statement that capillary staining is noted after 48 hours is incorrect; if the vessels are thrombosed or destroyed, staining will not reappear in that timeframe. In contrast, superficial partial-thickness burns show brisk capillary refill. **Analysis of Other Options:** * **A. Deeper parts of dermis involved:** This is the definition of a deep partial-thickness burn. It extends into the reticular dermis, unlike superficial partial-thickness burns which only involve the papillary dermis. [1] * **C. Skin is completely anaesthetized:** Because the burn extends deep into the dermis, it destroys most of the nerve endings. While superficial burns are exquisitely painful, deep partial-thickness burns often present with **decreased sensation (hypoalgesia)** or are relatively anesthetic to fine touch. [2] * **D. Heals with scarring:** Since the regenerative capacity of the membrane and superficial appendages is lost, these burns heal via secondary intention from the remaining deep hair follicles and sweat glands. [3] This process takes >3 weeks and characteristically results in **hypertrophic scarring** and contractures. [3] **High-Yield Clinical Pearls for NEET-PG:** * **Superficial Partial-Thickness:** Painful, blisters present, brisk capillary refill, heals without scarring (7–21 days). * **Deep Partial-Thickness:** Less painful, waxy white/mottled red appearance, absent/sluggish refill, heals with scarring (>21 days). * **Full-Thickness (3rd Degree):** Leathery, charred, painless, requires skin grafting. * **Rule of 9s:** Used for calculating Total Body Surface Area (TBSA) to initiate **Parkland Formula** (4ml x kg x %TBSA). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 633-634. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Skin, pp. 1144-1146. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 106-107.
Explanation: **Explanation:** Pathologic calcification is the abnormal deposition of calcium salts in tissues. It is broadly divided into two types: **Dystrophic** and **Metastatic** calcification. **Why Option D is the Correct Answer:** In **Dystrophic Calcification**, the deposition occurs locally in non-viable or dying tissues despite **normal serum calcium levels** and normal calcium metabolism [1]. In contrast, Metastatic Calcification occurs in normal tissues due to hypercalcemia (high serum calcium levels) [1], [2]. Therefore, saying serum calcium levels are high in dystrophic calcification is factually incorrect. **Analysis of Incorrect Options:** * **Option A (Occurs in damaged tissue):** This is a hallmark of dystrophic calcification. It occurs in areas of necrosis (coagulative, liquefactive, or caseous) and enzymatic fat necrosis [4]. * **Option B (Tuberculous lesions):** Tuberculosis often results in caseous necrosis. As the lesion heals or persists, it frequently undergoes dystrophic calcification (e.g., Ghon complex in lungs). * **Option C (Atherosclerotic lesions):** Calcification of the intimal plaques in advanced atherosclerosis is a classic example of dystrophic calcification, which can lead to narrowing of the vessel lumen. **High-Yield NEET-PG Pearls:** * **Morphology:** On H&E stain, calcium appears as **basophilic** (blue-purple), amorphous granular clumps [3]. * **Psammoma Bodies:** These are laminated, concentric calcified structures seen in specific tumors like Papillary Thyroid Carcinoma, Serous Cystadenocarcinoma of the ovary, and Meningioma [1]. They are a form of dystrophic calcification. * **Metastatic Calcification Sites:** Primarily affects interstitial tissues of the gastric mucosa, kidneys, lungs, and systemic arteries (tissues that lose acid and have an internal alkaline compartment) [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 134-135. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 127-128. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 76-77. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Disorders Involving Inflammatory And Haemopoietic Cells, pp. 655-656.
Explanation: **Explanation:** **Dermatomyositis (DM)** is an idiopathic inflammatory myopathy characterized by proximal muscle weakness and distinctive cutaneous manifestations. The presence of specific autoantibodies helps in predicting clinical phenotypes and systemic involvement. **Why Option A is correct:** **Anti-Mi2 antibodies** (targeting a component of the nucleosome remodeling deacetylase complex) are highly specific for Dermatomyositis. They are strongly associated with the **classic cutaneous hallmarks** of the disease, particularly the **Heliotrope rash** (periorbital violaceous edema) and **Gottron papules**. Patients with Anti-Mi2 antibodies generally have a **favorable prognosis**, a good response to corticosteroids, and a lower risk of interstitial lung disease (ILD) or malignancy compared to other antibody subtypes. **Why other options are incorrect:** * **Option B (Mechanic hands):** This hyperkeratotic, fissured skin change on the palms and lateral fingers is the classic hallmark of **Anti-Synthetase Syndrome** (associated with **Anti-Jo-1 antibodies**), not Anti-Mi2 [1]. * **Option C & D (Butterfly and Discoid rash):** These are characteristic cutaneous manifestations of **Systemic Lupus Erythematosus (SLE)**. While DM can sometimes present with a malar-like distribution, the Anti-Mi2 association specifically points toward the classic DM rash (Heliotrope). **High-Yield NEET-PG Pearls:** * **Anti-Jo-1:** Most common antibody in inflammatory myositis; associated with "Anti-synthetase syndrome" (ILD, Raynaud’s, Mechanic hands, Arthritis) [1]. * **Anti-MDA5:** Associated with **amyopathic dermatomyositis** and rapidly progressive ILD. * **Anti-TIF1-γ / Anti-NXP2:** Strongly associated with **paraneoplastic (malignancy-associated)** dermatomyositis in adults [1]. * **Muscle Biopsy:** Shows **perifascicular atrophy** (pathognomonic for DM) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, pp. 1240-1241.
Explanation: **Explanation:** **Apoptosis** is defined as a pathway of cell death induced by a tightly regulated intracellular program [1]. It is often referred to as **"programmed cell death"** or "cell suicide." In this process, cells activate enzymes (caspases) that degrade their own nuclear DNA and cytoplasmic proteins [2]. The cell membrane remains intact, but its structure is altered such that the cell becomes a target for phagocytosis, preventing an inflammatory response. **Analysis of Options:** * **Option A (Regeneration):** This refers to the replacement of damaged cells by cells of the same type (e.g., liver regeneration), which is a process of healing, not death. * **Option B (Reperfusion injury):** This is a specific type of cell injury that occurs when blood flow is restored to ischemic tissues, often leading to necrosis due to free radical generation. * **Option D (Uncontrolled multiplication):** This is the hallmark of **neoplasia** (cancer), where cells bypass regulatory checkpoints and fail to undergo apoptosis [4]. **High-Yield Facts for NEET-PG:** 1. **Morphology:** The most characteristic feature is **chromatin condensation** (pyknosis). Unlike necrosis, there is **no inflammation** and the cell size shrinks. 2. **Key Enzymes:** **Caspases** are the executioners. Caspase-3 is the common executioner caspase for both intrinsic and extrinsic pathways [2]. 3. **Mitochondrial (Intrinsic) Pathway:** Regulated by the **Bcl-2 family** [3]. Pro-apoptotic proteins (BAX, BAK) increase permeability, while anti-apoptotic proteins (Bcl-2, Bcl-xL) maintain membrane integrity. 4. **DNA Laddering:** On electrophoresis, apoptotic DNA shows a characteristic **step-ladder pattern** (180–200 base pair fragments), whereas necrotic DNA shows a "smear." **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-64. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-65. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 80-81. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 310.
Explanation: **Explanation:** **CD34** is a transmembrane glycoprotein primarily expressed on hematopoietic stem cells and vascular endothelium [1]. In surgical pathology, it serves as a marker for vascular tumors and specific mesenchymal neoplasms [1]. **Why Alveolar Soft Part Sarcoma (ASPS) is the correct answer:** While ASPS is classically defined by the **t(X;17)(p11;q25)** translocation resulting in the *ASPSCR1-TFE3* fusion, it characteristically demonstrates a rich, sinusoidal capillary network surrounding nests of tumor cells (organoid/pseudoalveolar pattern). **CD34** is used to highlight this characteristic **intricate vascular network**, which is a diagnostic hallmark of ASPS, aiding in its differentiation from other clear cell tumors. **Analysis of Incorrect Options:** * **Ewing’s Sarcoma:** The definitive marker is **CD99 (MIC2)**, showing a strong membranous staining pattern. It is also associated with the t(11;22) translocation. * **Myofibrosarcoma:** These tumors typically express myogenic markers like **SMA (Smooth Muscle Actin)** and Desmin. They are generally CD34 negative. * **Inflammatory Myofibroblastic Tumor (IMT):** The most specific marker is **ALK (Anaplastic Lymphoma Kinase)**, positive in approximately 50-60% of cases due to 2p23 rearrangements. **High-Yield Clinical Pearls for NEET-PG:** * **Other CD34+ Tumors:** Solitary Fibrous Tumor (SFT) - *strong/diffuse*, Dermatofibrosarcoma Protuberans (DFSP), Kaposi Sarcoma, and Angiosarcoma [1]. * **ASPS Key Fact:** It commonly affects young adults, involves the lower extremities, and has a high propensity for **brain metastasis**. * **PAS Stain:** ASPS shows PAS-positive, diastase-resistant rhomboid crystals. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 523-528.
Explanation: **Explanation:** **CD-99 (MIC2 gene product)** is a highly sensitive cell surface glycoprotein marker used in the diagnosis of **Ewing’s Sarcoma** and Peripheral Primitive Neuroectodermal Tumors (PNET). In Ewing’s sarcoma, CD-99 typically shows a characteristic **strong, diffuse membranous staining** pattern. While not 100% specific, it is the primary diagnostic marker used to differentiate Ewing’s from other "small round blue cell tumors." **Analysis of Incorrect Options:** * **Small Lymphocytic Lymphoma (SLL):** This is a B-cell neoplasm characterized by markers like **CD5, CD19, CD20, and CD23**. CD-99 is not used for its diagnosis. * **Dermatofibroma:** This is a common benign fibrous histiocytoma of the skin. The characteristic immunohistochemical marker is **Factor XIIIa**, and it is typically negative for CD34 (unlike Dermatofibrosarcoma Protuberans). * **Malignant Fibrous Histiocytoma (MFH):** Now largely reclassified as Pleomorphic Undifferentiated Sarcoma, it lacks a specific single marker like CD-99 and is often a diagnosis of exclusion. **High-Yield NEET-PG Pearls:** * **Genetics:** Ewing’s sarcoma is associated with the **t(11;22)(q24;q12)** translocation, resulting in the **EWS-FLI1** fusion gene. * **Morphology:** On H&E stain, it appears as a **"Small Round Blue Cell Tumor"** with Homer-Wright rosettes (in PNET variants) and PAS-positive glycogen in the cytoplasm. * **Radiology:** Classically presents with an **"Onion-skin"** periosteal reaction. * **Other CD-99 positive tumors:** Though less common, CD-99 can also be positive in Lymphoblastic Lymphoma, Synovial Sarcoma, and Solitary Fibrous Tumor [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1225-1226.
Explanation: **Explanation:** Hydropic swelling (also known as vacuolar degeneration or cloudy swelling) is the **earliest manifestation of almost all forms of cell injury** [1]. It occurs when the cell fails to maintain ionic and fluid homeostasis [2]. **Why Option A is the Correct Answer:** In hydropic swelling, the cell does **not** increase the number of its organelles. Instead, the organelles (especially the mitochondria and endoplasmic reticulum) undergo **swelling and structural distortion** [3]. An increase in the number of organelles is typically seen in cellular adaptations like hypertrophy or induction of the smooth ER, not in acute reversible injury. **Analysis of Incorrect Options:** * **D & C: Influx of sodium and Impairment of volume regulation:** The primary mechanism of hydropic swelling is the failure of the energy-dependent **Na+/K+ ATPase pump** (due to ATP depletion) [4]. This leads to an accumulation of intracellular sodium. Since water follows sodium to maintain osmotic equilibrium, the cell swells, representing a failure of volume regulation [2]. * **B: Dilatation of cisternae of ER:** As water enters the cell, it accumulates within the cisternae of the endoplasmic reticulum, causing them to distend and form small, clear vacuoles (vacuolar degeneration). **NEET-PG High-Yield Pearls:** * **Reversibility:** Hydropic swelling is a **reversible** change [1]. If the stimulus is removed, the cell returns to its normal state. * **Gross Appearance:** Affected organs (like the kidney or liver) appear pale, have increased weight, and show rounded margins. * **Microscopy:** Look for "cloudy" cytoplasm and small clear vacuoles [2]. * **Distinction:** Do not confuse hydropic swelling with fatty change; in hydropic swelling, the nucleus remains central, whereas in fatty change, it may be displaced to the periphery [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 49-50. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 51-53. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 53-55. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 56-57.
Cell Injury and Cell Death
Practice Questions
Adaptations of Cellular Growth
Practice Questions
Accumulations and Deposits
Practice Questions
Acute and Chronic Inflammation
Practice Questions
Tissue Repair and Wound Healing
Practice Questions
Hemodynamic Disorders
Practice Questions
Genetic Disorders
Practice Questions
Environmental Pathology
Practice Questions
Nutritional Diseases
Practice Questions
Molecular Basis of Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free